How is mononucleosis treated?
Pro Research Analysisby 
Searched over 200M research papers
Treatment of Infectious Mononucleosis
Overview of Infectious Mononucleosis
Infectious mononucleosis, commonly known as "mono" or the "kissing disease," is primarily caused by the Epstein-Barr virus (EBV). It is characterized by symptoms such as fever, pharyngitis, lymphadenopathy, and fatigue2 9. The disease is usually self-limiting, with symptoms typically resolving within two to three weeks, although fatigue can persist for longer periods2 6.
Symptomatic Treatment and Supportive Care
Rest and Hydration
The cornerstone of treatment for infectious mononucleosis is supportive care. This includes adequate rest, hydration, and the use of analgesics to manage pain and fever6 9. Patients are often advised to avoid strenuous activities, especially contact sports, to reduce the risk of splenic rupture, a rare but serious complication9.
Analgesics and Antipyretics
Over-the-counter pain relievers such as acetaminophen or ibuprofen can be used to alleviate symptoms like sore throat and fever6. These medications help improve patient comfort during the acute phase of the illness.
Antiviral Therapy
Acyclovir and Valacyclovir
Antiviral agents such as acyclovir and valacyclovir have been studied for their potential role in treating infectious mononucleosis, particularly in severe cases. Some studies suggest that these antivirals may help reduce the viral load and alleviate symptoms, although their overall efficacy remains uncertain1 3 5. Acyclovir, in combination with prednisolone, has been shown to inhibit oropharyngeal EBV replication but did not significantly affect the duration of clinical symptoms3.
Novel Antiviral Agents
Recent research has explored novel antiviral agents, including 5-substituted uracil, azacytosine derivatives, and peptides that inhibit EBV-mediated membrane fusion. These agents show promise in treating severe cases of infectious mononucleosis, although more research is needed to confirm their efficacy1.
Corticosteroid Use
Efficacy and Safety
Corticosteroids, such as prednisolone, have been used to manage severe symptoms of infectious mononucleosis, including significant pharyngeal swelling and respiratory distress. However, the evidence supporting their routine use is limited and mixed. Some studies have found that steroids can provide short-term relief of sore throat and other symptoms, but these benefits are not consistently maintained2 8. Additionally, the potential side effects and long-term complications of steroid use warrant cautious consideration2 8.
Combination with Antivirals
In some cases, corticosteroids are used in combination with antiviral agents to manage severe manifestations of the disease. This combination therapy has shown some benefit in reducing pharyngeal discomfort and other symptoms, although the overall impact on the disease course remains unclear2 5.
Alternative Treatments
Chinese Herbal Medicine
Chinese herbal medicine has been evaluated for its efficacy in treating children's infectious mononucleosis. Studies have shown that herbal decoctions can effectively reduce fever and cervical lymph node swelling, with a safety profile comparable to conventional antiviral treatments like ganciclovir4. These findings suggest that traditional Chinese medicine may offer a viable alternative for managing symptoms and improving immune function in pediatric patients.
Conclusion
The treatment of infectious mononucleosis primarily involves supportive care, including rest, hydration, and analgesics. Antiviral agents and corticosteroids may be considered in severe cases, although their routine use is not universally recommended due to mixed evidence on their efficacy and safety. Alternative treatments, such as Chinese herbal medicine, show promise, particularly in pediatric cases. Further research is needed to develop more effective and targeted therapies for infectious mononucleosis.
Sources and full results
Most relevant research papers on this topic
Current diagnosis and management of infectious mononucleosis
RT-PCR and EBV-VL measurements may aid in early diagnosis, and antiviral agents may be useful treatments for severe infectious mononucleosis.
Systematic Review
Highly CitedSteroids for symptom control in infectious mononucleosis.
Steroids show potential for short-term symptom control in infectious mononucleosis, but more research is needed to confirm their effectiveness and safety.
Systematic Review
Very Rigorous JournalAcyclovir and prednisolone treatment of acute infectious mononucleosis: a multicenter, double-blind, placebo-controlled study.
Acyclovir combined with prednisolone effectively inhibited oropharyngeal Epstein-Barr virus replication in infectious mononucleosis patients without affecting clinical symptoms or developing EBV-specific cellular immunity.
RCTHighly CitedClinically controlled study on children’s infectious mononucleosis treated by Chinese medicine
Chinese herbs effectively and safely treat children's infectious mononucleosis, improving clinical symptoms and showing a certain effect on immune regulation.
RCTAntiviral treatment for severe EBV infections in apparently immunocompetent patients.
Antiviral agents may be considered as an adjunct to steroid treatment for severe EBV infections in immunocompetent patients.
Systematic ReviewHighly CitedHow I Manage Infectious Mononucleosis
Infectious mononucleosis symptoms subside in three to five days, and recovery time varies depending on the patient's age and activity level.
Recovery from infectious mononucleosis: a case for more than symptomatic therapy? A systematic review.
Activity and early bed rest can speed recovery from infectious mononucleosis, while drug therapy shows no evidence of shortening recovery time.
Systematic ReviewNo new evidence to support the routine use of steroids in the treatment of infectious mononucleosis
Steroids for symptom control in infectious mononucleosis have not been consistently shown to be effective, with insufficient evidence and poor trial quality to recommend their routine use.
Systematic ReviewReturn to Play After Infectious Mononucleosis
Return-to-play decisions for athletes with infectious mononucleosis need to be individualized due to variable disease course and lack of evidence-based guidelines.
Systematic Review
Rigorous JournalInfectious mononucleosis
Infectious mononucleosis is caused by Epstein-Barr virus (EBV) and can lead to long-term complications like Hodgkin lymphoma and multiple sclerosis.
Rigorous JournalHighly Cited